We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilis and Intrexon Collaborate on Rare Diseases

News   Jan 03, 2014

 
Agilis and Intrexon Collaborate on Rare Diseases
 
 
 

RELATED ARTICLES

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

Arsenic Harnessed to Create Broad-Spectrum Antibiotic

News

Although it contains arsenic, researchers say they tested the antibiotic's toxicity on human blood cells and reported that “it doesn’t kill human cells in tissue culture.”

READ MORE

Engineering Accuracy in CRISPR

News

Biomedical engineers have developed a method for improving the accuracy of the CRISPR genome editing technology by an average of 50-fold.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE